Century Therapeutics (IPSC) Interest Coverage Ratio (2020 - 2026)
Century Therapeutics' (IPSC) quarterly Interest Coverage Ratio came in at 0.34 in Q1 2026, down 100.18% year-on-year from 186.84 in Q1 2025, and up 99.99% on a QoQ basis from 3441.83 in Q4 2025.
Century Therapeutics (IPSC) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Interest Coverage Ratio data on file, last reported at 0.34 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 100.18% year-over-year to 0.34 in Q1 2026; TTM through Mar 2026 was 1.66, a 93.54% increase from a year earlier, with the FY2025 full-year figure at 17.17, down 2288.79% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.34, up from 3441.83 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for IPSC reached as high as 951.35 in Q4 2023 and fell as low as 3441.83 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 170.96 across 5 years, with a median of 1.68 in 2025.
- On a YoY basis, Interest Coverage Ratio climbed as much as 48954.21% in 2025 and fell as far as 1774441.84% in 2025.
- Year by year, Interest Coverage Ratio stood at 107.44 in 2022, then jumped by 985.48% to 951.35 in 2023, then slumped by 100.02% to 0.19 in 2024, then sank by 1774441.84% to 3441.83 in 2025, then jumped by 99.99% to 0.34 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.34 in Q1 2026, 3441.83 in Q4 2025, and 1.68 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | -3,441.83 |
| Sep 30, 2025 | -1.68 |
| Jun 30, 2025 | -1.44 |
| Mar 31, 2025 | 186.84 |
| Dec 31, 2024 | -0.19 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.37 |
| Mar 31, 2024 | -0.38 |
| Dec 31, 2023 | 951.35 |
| Sep 30, 2023 | -69.31 |
| Jun 30, 2023 | -4.36 |
| Mar 31, 2023 | -79.41 |
| Dec 31, 2022 | -107.44 |
| Sep 30, 2022 | -85.09 |
| Jun 30, 2022 | -95.00 |
| Mar 31, 2022 | -157.29 |
| Dec 31, 2021 | -1,864.87 |
| Sep 30, 2021 | -80.21 |
| Jun 30, 2021 | -72.39 |